SUPPORT for Patients and Communities Reauthorization Act of 2025
Official title: A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SUPPORT for Patients and Communities Reauthorization Act of 2025
This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.
For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to
• addressing substance use disorders with respect to pregnant and postpartum women,
• prevention and recovery from substance use disorders for youth,
• housing for individuals in recovery from substance use disorders,
• community organizations facilitating recovery from substance use disorders,
• loan repayment for certain health care providers treating substance use disorders,
• prevention of overdoses of controlled substances,
• treatment of children experiencing psychological trauma, and
• mental and behavioral health education and training for medical and allied health students.
Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.
Additionally, the bill establishes new requirements for HHS, including requirements relating to
• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.
- Introduced in Senate Formatted Text PDF Formatted XML
- TRUST FOR AMERICA'S HEALTH
- TRUST FOR AMERICA'S HEALTH
- TRUST FOR AMERICA'S HEALTH
- WHEAT SHROYER GOVERNMENT RELATIONS LLC
- AMERICAN PSYCHIATRIC ASSOCIATION
- MARCUS G. FAUST, PC
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Education, Dept of
- Office of Management & Budget (OMB)
- Executive Office of the President (EOP)
- Environmental Protection Agency (EPA)
Cite this page
U.S. Congress. (2026). S. 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-2121/
"S. 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-2121/.
S. 2121, 119th Cong. (2026), https://openamerica.io/bill/119-S-2121/.
[S. 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025](https://openamerica.io/bill/119-S-2121/)